June 19 (SeeNews) - Serbia's largest drug manufacturer Hemofarm, owned by Germany's STADA, said on Thursday it raised its stake in its local subsidiary Zorka Pharma to 90.5% through an 864 million dinars ($16.8 million/10.8 million euro) buyout bid.